David A Greene

US Patent:

7787945, Aug 31, 2010

Filed:

Mar 8, 2006

Appl. No.:

11/371701

Inventors:

David Greene - Fort Wayne IN, US

Assignee:

NeuroPace, Inc. - Mountain View CA

International Classification:

A61B 5/04

US Classification:

600544, 600545

Abstract:

An implantable seizure monitor can include at least one sensing electrode and an electronics module configured to detect, record and/or log neurological events. For example, the electronics module can be configured to detect brainwaves indicative of seizures, such as, for example, epileptic seizures, and to create a log indicating when such seizures occur. The implantable seizure monitor can include a cushioning member made of a soft material and configured to be implantable between the epidermis and cranium of a patient.

US Patent:

8131352, Mar 6, 2012

Filed:

Jun 20, 2007

Appl. No.:

11/765574

Inventors:

David A. Greene - Fort Wayne IN, US

Assignee:

NeuroPace, Inc. - Mountain View CA

International Classification:

A61B 5/04

US Classification:

600544, 600545

Abstract:

Methods and systems for detecting neurological events and approximating a target detection rate are disclosed. A target detection rate may be identified for the neurological event. Electrographic signals incident on a neurological event detector may be monitored. Each signal may be compared to a threshold value for a parameter. As the threshold value varies, it has a predictable effect on a detection rate of the neurological event. A rate at which the electrographic signals exceed the threshold value may be measured and compared to the target detection rate. The threshold value may be adjusted to minimize the difference between the measured detection rate and the target detection rate.

US Patent:

8140150, Mar 20, 2012

Filed:

Apr 29, 2010

Appl. No.:

12/770643

Inventors:

David Greene - Fort Wayne IN, US

Assignee:

NeuroPace, Inc - Mountain View CA

International Classification:

A61B 5/04

US Classification:

600544, 600545

Abstract:

An implantable seizure monitor can include at least one sensing electrode and an electronics module configured to detect, record and/or log neurological events. For example, the electronics module can be configured to detect brainwaves indicative of seizures, such as, for example, epileptic seizures, and to create a log indicating when such seizures occur. The implantable seizure monitor can include a cushioning member made of a soft material and configured to be implantable between the epidermis and cranium of a patient.

US Patent:

8140151, Mar 20, 2012

Filed:

Apr 29, 2010

Appl. No.:

12/770697

Inventors:

David Greene - Fort Wayne IN, US

Assignee:

NeuroPace, Inc. - Mountain View CA

International Classification:

A61B 5/04

US Classification:

600544, 600545

Abstract:

An implantable seizure monitor can include at least one sensing electrode and an electronics module configured to detect, record and/or log neurological events. For example, the electronics module can be configured to detect brainwaves indicative of seizures, such as, for example, epileptic seizures, and to create a log indicating when such seizures occur. The implantable seizure monitor can include a cushioning member made of a soft material and configured to be implantable between the epidermis and cranium of a patient.

US Patent:

8224434, Jul 17, 2012

Filed:

May 11, 2011

Appl. No.:

13/105717

Inventors:

David Greene - Fort Wayne IN, US

Assignee:

NeuroPace, Inc. - Mountain View CA

International Classification:

A61B 5/04

US Classification:

600544, 600545

Abstract:

An implantable seizure monitor can include at least one sensing electrode and an electronics module configured to detect, record and/or log neurological events. For example, the electronics module can be configured to detect brainwaves indicative of seizures, such as, for example, epileptic seizures, and to create a log indicating when such seizures occur. The implantable seizure monitor can include a cushioning member made of a soft material and configured to be implantable between the epidermis and cranium of a patient.

US Patent:

20060015391, Jan 19, 2006

Filed:

Jun 8, 2005

Appl. No.:

11/147274

Inventors:

David Greene - Washington DC, US
Marvin Randolph - Washington DC, US

International Classification:

G06Q 99/00

US Classification:

705010000

Abstract:

An automated voter registration campaign management system and method includes collecting information and determining of one or more parameters of registrations per hour, phone number percentages for new registrants, volunteer recruitment percentage, contact rate and verification rate. Next the determined parameters is compared against predetermined targets; and a variance report is generated.

US Patent:

20120143297, Jun 7, 2012

Filed:

Dec 2, 2011

Appl. No.:

13/310695

Inventors:

David Greene - Fort Wayne IN, US

International Classification:

A61N 1/05

US Classification:

607116

Abstract:

A lead fixation device for securing a medical lead in a human patient includes: a single-piece structure comprising: a top surface; a bottom surface; an outer perimeter; and an inner perimeter, the inner perimeter comprising: a diameter approximately equal to or smaller than a diameter of a burr hole into which the lead fixation device is designed to be deployed; a central bore extending longitudinally from the top surface through to the bottom surface, a portion of the central bore being located in approximately a center of the lead fixation device and comprising a central bore diameter; and at least one retention tract formed in the top surface of a cap of the lead fixation device, the retention tract configured for retaining, with an interference fit, a portion of a body of the medical lead in the lead fixation device.

US Patent:

20220314002, Oct 6, 2022

Filed:

Mar 30, 2022

Appl. No.:

17/709227

Inventors:

- Mountain View CA, US
David A. Greene - Fort Wayne IN, US

International Classification:

A61N 1/36
A61N 1/05

Abstract:

An implanted neurostimulation system is configured to sense episodes of electrographic events and determine durations of episodes. Durations of electrographic events sensed by the implanted neurostimulation system are mapped with seizure probability biomarkers derived from records of the electrographic events to create a mapping function. A seizure probability biomarker that has a value desired for the operation of the implanted neurostimulation system is selected. The duration mapped to the selected seizure probability biomarker is identified and programmed into a control module of the implanted neurostimulation system as a programmed parameter that triggers the operation by the implanted neurostimulation system. The process may be repeated for other operations of the implanted neurostimulation system.